nitinol has been researched along with Urinary-Tract-Infections* in 2 studies
1 review(s) available for nitinol and Urinary-Tract-Infections
Article | Year |
---|---|
What's New in TIND?
There is growing interest in minimally invasive (MI) treatment options for male lower urinary tract symptoms (LUTS). Among these options, the temporary implantable nitinol device (TIND; Medi-Tate, Or Akiva, Israel) is a novel instrument used to alleviate symptoms by creating incisions in the prostate via mechanical stress.. To review recent data for TIND as an MI procedure to improve LUTS.. Medline, PubMed, the Cochrane Database, and Embase were screened for clinical trials, randomized controlled trials, and review articles on the use of TIND in patients with male LUTS.. Preliminary data suggest that TIND is a safe and effective MI technique for patients with male LUTS. Symptom relief and increase in urinary flow after 36mo are promising. However, long-term results are needed.. Various treatment options for male patients suffering from urinary voiding symptoms are emerging. TIND, a temporary implantable nitinol device, appears to be a safe option that improves symptoms without affecting sexuality. Topics: Alloys; Clinical Trials as Topic; Humans; Israel; Lower Urinary Tract Symptoms; Male; Minimally Invasive Surgical Procedures; Postoperative Complications; Prostate; Prostatic Hyperplasia; Prostheses and Implants; Randomized Controlled Trials as Topic; Stress, Mechanical; Urinary Retention; Urinary Tract Infections | 2018 |
1 trial(s) available for nitinol and Urinary-Tract-Infections
Article | Year |
---|---|
Comparison of nitinol urethral stent infections with indwelling catheter-associated urinary-tract infections.
To determine the efficacy of intraurethral metal stents in preventing or eradicating urinary-tract infections (UTI) during the management of bladder outlet obstruction (BOO) by comparing the frequency and nature of the infections with indwelling-catheter-associated UTI.. The SAS relative-risk test was used to compare the risks of UTI in 76 patients with temporary urethral stents, 60 patients with BOO who had never been catheterized nor stented, and 34 patients with a permanent indwelling urethral catheter (PIUC). Infection was assessed 1 month after placement of the devices. Scanning electron microscopy (SEM) of the proximal and distal pieces of the stents removed from five patients with and five patients without UTI was carried out in a search for predisposing changes on the surfaces.. After insertion of the catheter, UTI developed in 79.4% of the patients who originally had sterile urine. However, after insertion of the stent, UTI developed in only 40.9% of the patients with sterile urine. In 21 (44.6%) of the catheterized patients who had infected urine, UTI was eradicated after stent insertion. The SEM analysis of the stents showed that a thick organic layer had formed only on the infected devices but with no sign of erosion.. Urinary infection is a significant problem in patients with PIUC but is significantly less frequent and less severe in patients with urethral stents. This advantage of stents over the conventional urethral catheter, in addition to their obvious convenience for the patient, make them good alternatives to reduce the risk of UTI. Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alloys; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Prevalence; Radiography; Risk Factors; Stents; Urethra; Urinary Bladder Neck Obstruction; Urinary Catheterization; Urinary Tract Infections; Urination; Urination Disorders | 2006 |